Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |